Warwick Evidence has published their latest report on beta interferon and glatiramer acetate:

Melendez-Torres G, Auguste P, Armoiry X, Maheswaran H, Court R, Madan J, Kan A, Lin S, Counsell C, Patterson J, Rodrigues J, Ciccarelli O, Fraser H & Clarke A. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation. Health Technol Assess 2017;21(52)

Please find the complete report here.

Clinical Advisor featured a study by Dr Chidozie U. Nduka that has found that antiretroviral therapy (ART) may be the single most consistent determinant of diabetes in patients with HIV.

Heller S, Amiel S, Campbell, M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R, Mansell P, Waugh N, White D. Relative effectivenes s of ins ulin pump treatment over multiple daily injections and s tructured education during flexible intens ive ins ulin treatment for type 1 diabetes : clus ter randomis ed trial (REPOSE). BMJ 2017;356:j1285 doi: 10.1136/bmj.j1285. http://www.bmj.com/content/356/bmj.j1285